Search for: "Endo Pharmaceuticals Inc." Results 121 - 140 of 161
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Jun 2016, 6:40 am by Dennis Crouch
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Exhaustion: Impression Products, Inc. v. [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
20 Jan 2016, 8:00 am by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
12 Jan 2016, 11:39 am by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
1 Jan 2016, 9:00 am by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
8 May 2008, 12:22 pm
Wyeth Pharmaceuticals, 2008 WL 1821379 (5th Cir. [read post]
4 Mar 2016, 12:25 pm by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
17 Feb 2016, 9:20 am by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
3 Feb 2016, 8:57 am by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
18 May 2016, 8:19 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]